These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23380736)

  • 1. Postembolization syndrome after hepatic transarterial chemoembolization: effect of prophylactic steroids on postprocedure medication requirements.
    Kogut MJ; Chewning RH; Harris WP; Hippe DS; Padia SA
    J Vasc Interv Radiol; 2013 Mar; 24(3):326-31. PubMed ID: 23380736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone Prophylaxis to Alleviate Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Study.
    Yang H; Seon J; Sung PS; Oh JS; Lee HL; Jang B; Chun HJ; Jang JW; Bae SH; Choi JY; Yoon SK
    J Vasc Interv Radiol; 2017 Nov; 28(11):1503-1511.e2. PubMed ID: 28941589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of prophylactic antiemetic treatment in cancer patients receiving radiotherapy.
    Mystakidou K; Kouloulias V; Nikolaou V; Tsilika E; Lymperopoulou G; Balafouta M; Kouvaris I; Kelekis A; Gouliamos A
    J BUON; 2010; 15(1):29-35. PubMed ID: 20414924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of palonosetron and dexamethasone administration on the prevention of gastrointestinal symptoms in hepatic arterial chemoembolization with epirubicin.
    Sakamoto T; Saito Y; Kobayashi M; Yamada T; Takekuma Y; Nakai M; Ogawa K; Iseki K; Sugawara M
    Support Care Cancer; 2020 Jul; 28(7):3251-3257. PubMed ID: 31732854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of preventive administration of antiemetic drugs on risk of acute nausea and vomiting induced by transcatheter arterial chemoembolization in patients with hepatocellular carcinomas - a retrospective study].
    Kabuki M; Higashihara H; Kakuda M; Fujita Y; Masuda J; Kin K; Ueguchi T; Osuga K; Tomiyama N
    Gan To Kagaku Ryoho; 2013 Feb; 40(2):197-201. PubMed ID: 23411955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Opioid Medication Use after Conventional Chemoembolization versus Drug-Eluting Embolic Chemoembolization.
    Khalaf MH; Shah RP; Green V; Vezeridis AM; Liang T; Kothary N
    J Vasc Interv Radiol; 2020 Aug; 31(8):1292-1299. PubMed ID: 32654960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of 5-HT(3) RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting.
    Schwartzberg L; Jackson J; Jain G; Balu S; Buchner D
    Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):481-8. PubMed ID: 21711119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration.
    Lee SH; Hahn ST; Park SH
    Cardiovasc Intervent Radiol; 2001; 24(6):368-71. PubMed ID: 11907741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoembolization for hepatocellular carcinoma: effect of intraarterial lidocaine in peri- and post-procedural pain and hospitalization.
    Romano M; Giojelli A; Tamburrini O; Salvatore M
    Radiol Med; 2003 Apr; 105(4):350-5. PubMed ID: 12835628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma.
    Lance C; McLennan G; Obuchowski N; Cheah G; Levitin A; Sands M; Spain J; Srinivas S; Shrikanthan S; Aucejo FN; Kim R; Menon KV
    J Vasc Interv Radiol; 2011 Dec; 22(12):1697-705. PubMed ID: 21983055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoembolization in patients at high risk: results and complications.
    Kiely JM; Rilling WS; Touzios JG; Hieb RA; Franco J; Saeian K; Quebbeman EJ; Pitt HA
    J Vasc Interv Radiol; 2006 Jan; 17(1):47-53. PubMed ID: 16415132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
    Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
    Pietrosi G; Miraglia R; Luca A; Vizzini GB; Fili' D; Riccardo V; D'Antoni A; Petridis I; Maruzzelli L; Biondo D; Gridelli B
    J Vasc Interv Radiol; 2009 Jul; 20(7):896-902. PubMed ID: 19497762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial on single dose steroid before thyroidectomy for benign disease to improve postoperative nausea, pain, and vocal function.
    Worni M; Schudel HH; Seifert E; Inglin R; Hagemann M; Vorburger SA; Candinas D
    Ann Surg; 2008 Dec; 248(6):1060-6. PubMed ID: 19092351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein.
    Kim HC; Lee JH; Chung JW; Kang B; Yoon JH; Kim YJ; Lee HS; Jae HJ; Park JH
    J Vasc Interv Radiol; 2013 Feb; 24(2):274-83. PubMed ID: 23369561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: a prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens.
    Pan PH; Lee SC; Harris LC
    Anesth Analg; 2008 Aug; 107(2):429-38. PubMed ID: 18633020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiemetic efficacy of an oral suspension of granisetron plus dexamethasone and influence of quality of life on risk for nausea and vomiting.
    Jordan K; Grothey A; Kegel T; Fibich C; Schöbert C
    Onkologie; 2005 Feb; 28(2):88-92. PubMed ID: 15662112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.